vs
Avalon GloboCare Corp.（ALBT）与Cycurion, Inc.（CYCU）财务数据对比。点击上方公司名可切换其他公司
Cycurion, Inc.的季度营收约是Avalon GloboCare Corp.的10.1倍（$3.5M vs $350.1K）。Avalon GloboCare Corp.净利率更高（-72.6% vs -141.2%，领先68.6%）。Avalon GloboCare Corp.同比增速更快（1.4% vs -13.1%）。过去两年Avalon GloboCare Corp.的营收复合增速更高（4.4% vs -8.6%）
Avalon GloboCare Corp.是一家全球化生物技术与医疗服务提供商，专注于细胞与基因疗法研发、再生医学解决方案落地及转化医学研究创新，业务覆盖北美及亚洲核心市场，为医疗相关主体提供定制化专业服务。
ALBT vs CYCU — 直观对比
营收规模更大
CYCU
是对方的10.1倍
$350.1K
营收增速更快
ALBT
高出14.5%
-13.1%
净利率更高
ALBT
高出68.6%
-141.2%
两年增速更快
ALBT
近两年复合增速
-8.6%
损益表 — Q3 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $350.1K | $3.5M |
| 净利润 | $-254.3K | $-5.0M |
| 毛利率 | — | 12.1% |
| 营业利润率 | -21.8% | -141.7% |
| 净利率 | -72.6% | -141.2% |
| 营收同比 | 1.4% | -13.1% |
| 净利润同比 | 84.9% | -546.8% |
| 每股收益（稀释后） | $-0.06 | $-11.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALBTCYCU
| Q4 25 | — | $3.5M | ||
| Q3 25 | $350.1K | $3.8M | ||
| Q2 25 | $350.4K | $3.9M | ||
| Q1 25 | $349.8K | $3.9M | ||
| Q4 24 | $345.8K | $4.1M | ||
| Q3 24 | $345.2K | $4.5M | ||
| Q2 24 | $327.9K | $5.0M | ||
| Q1 24 | $314.6K | $4.2M |
净利润ALBTCYCU
| Q4 25 | — | $-5.0M | ||
| Q3 25 | $-254.3K | $-3.1M | ||
| Q2 25 | $-13.5M | $-5.3M | ||
| Q1 25 | $-2.5M | $-10.2M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-1.7M | $116.1K | ||
| Q2 24 | $-2.1M | $306.1K | ||
| Q1 24 | $-1.4M | $-312.5K |
毛利率ALBTCYCU
| Q4 25 | — | 12.1% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 37.9% | ||
| Q3 24 | — | 16.1% | ||
| Q2 24 | — | 20.5% | ||
| Q1 24 | — | 8.2% |
营业利润率ALBTCYCU
| Q4 25 | — | -141.7% | ||
| Q3 25 | -21.8% | -118.2% | ||
| Q2 25 | -1109.6% | -96.9% | ||
| Q1 25 | -516.5% | -260.9% | ||
| Q4 24 | — | 31.9% | ||
| Q3 24 | -367.9% | 9.4% | ||
| Q2 24 | -458.8% | 14.6% | ||
| Q1 24 | -268.0% | -0.8% |
净利率ALBTCYCU
| Q4 25 | — | -141.2% | ||
| Q3 25 | -72.6% | -81.5% | ||
| Q2 25 | -3840.9% | -136.1% | ||
| Q1 25 | -709.6% | -264.8% | ||
| Q4 24 | — | 27.5% | ||
| Q3 24 | -486.5% | 2.6% | ||
| Q2 24 | -650.2% | 6.1% | ||
| Q1 24 | -434.7% | -7.4% |
每股收益（稀释后）ALBTCYCU
| Q4 25 | — | $-11.09 | ||
| Q3 25 | $-0.06 | $-1.59 | ||
| Q2 25 | $-6.22 | $-0.15 | ||
| Q1 25 | $-1.43 | $-0.56 | ||
| Q4 24 | — | $1.56 | ||
| Q3 24 | $-1.82 | $0.11 | ||
| Q2 24 | $-2.85 | $0.01 | ||
| Q1 24 | $-1.86 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.9K | $5.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-4.5M | $20.1M |
| 总资产 | $9.1M | $33.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ALBTCYCU
| Q4 25 | — | $5.3M | ||
| Q3 25 | $333.9K | $3.7M | ||
| Q2 25 | $201.5K | $1.0M | ||
| Q1 25 | $1.4M | — | ||
| Q4 24 | — | $38.7K | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $200.6K | — | ||
| Q1 24 | $305.5K | — |
股东权益ALBTCYCU
| Q4 25 | — | $20.1M | ||
| Q3 25 | $-4.5M | $19.1M | ||
| Q2 25 | $-7.1M | $14.0M | ||
| Q1 25 | $-3.9M | $12.9M | ||
| Q4 24 | — | $3.5M | ||
| Q3 24 | $5.4M | $-3.7M | ||
| Q2 24 | $4.4M | $-3.4M | ||
| Q1 24 | $6.1M | $-2.8M |
总资产ALBTCYCU
| Q4 25 | — | $33.5M | ||
| Q3 25 | $9.1M | $32.3M | ||
| Q2 25 | $8.0M | $30.7M | ||
| Q1 25 | $10.6M | $31.5M | ||
| Q4 24 | — | $25.6M | ||
| Q3 24 | $19.6M | $2.9M | ||
| Q2 24 | $19.5M | $2.7M | ||
| Q1 24 | $20.3M | $3.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.4M | $-3.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-3.5M |
| 自由现金流率自由现金流/营收 | — | -98.8% |
| 资本支出强度资本支出/营收 | — | 5.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-12.5M |
8季度趋势，按日历期对齐
经营现金流ALBTCYCU
| Q4 25 | — | $-3.3M | ||
| Q3 25 | $-1.4M | $-2.5M | ||
| Q2 25 | $-1.2M | $-3.6M | ||
| Q1 25 | $-1.8M | $-2.7M | ||
| Q4 24 | $-1.1M | $-205.7K | ||
| Q3 24 | $-1.9M | $-315.2K | ||
| Q2 24 | $-1.1M | $-578.0K | ||
| Q1 24 | $-915.7K | $-272.4K |
自由现金流ALBTCYCU
| Q4 25 | — | $-3.5M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-3.7M | ||
| Q1 25 | — | $-2.8M | ||
| Q4 24 | — | $-310.7K | ||
| Q3 24 | — | $-420.2K | ||
| Q2 24 | — | $-711.0K | ||
| Q1 24 | — | $-377.4K |
自由现金流率ALBTCYCU
| Q4 25 | — | -98.8% | ||
| Q3 25 | — | -66.9% | ||
| Q2 25 | — | -94.2% | ||
| Q1 25 | — | -72.7% | ||
| Q4 24 | — | -7.6% | ||
| Q3 24 | — | -9.4% | ||
| Q2 24 | — | -14.2% | ||
| Q1 24 | — | -8.9% |
资本支出强度ALBTCYCU
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.5% |
现金转化率ALBTCYCU
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.18× | ||
| Q3 24 | — | -2.71× | ||
| Q2 24 | — | -1.89× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
